Guido Gerken

34.7k total citations · 4 hit papers
588 papers, 23.1k citations indexed

About

Guido Gerken is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Guido Gerken has authored 588 papers receiving a total of 23.1k indexed citations (citations by other indexed papers that have themselves been cited), including 345 papers in Hepatology, 290 papers in Epidemiology and 149 papers in Surgery. Recurrent topics in Guido Gerken's work include Liver Disease Diagnosis and Treatment (202 papers), Hepatitis C virus research (167 papers) and Hepatitis B Virus Studies (130 papers). Guido Gerken is often cited by papers focused on Liver Disease Diagnosis and Treatment (202 papers), Hepatitis C virus research (167 papers) and Hepatitis B Virus Studies (130 papers). Guido Gerken collaborates with scholars based in Germany, United States and United Kingdom. Guido Gerken's co-authors include Ali Canbay, Elke Cario, Daniel K. Podolsky, Percy A. Knolle, Lars P. Bechmann, JF Schlaak, Ulrich Treichel, Karl‐Hermann Meyer zum Büschenfelde, Ansgar W. Lohse and Michael P. Manns and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Guido Gerken

573 papers receiving 22.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

2005 866 citations Harry L.A. Janssen, Monika van Zonneveld et al. The Lancet profile →
The interaction of hepatic lipid and glucose metabolism in liver diseases

2011 762 citations Lars P. Bechmann, Guido Gerken et al. Journal of Hepatology profile →
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial

2012 656 citations Antonio Craxı̀, Guido Gerken et al. Journal of Hepatology profile →
Toll-Like Receptor 2 Controls Mucosal Inflammation by Regulating Epithelial Barrier Function

2007 568 citations Guido Gerken et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Guido Gerken	11.6k	11.6k	4.9k	3.7k	3.3k	588	23.1k
Gideon M. Hirschfield	11.2k 1.0×	9.7k 0.8×	7.8k 1.6×	2.6k 0.7×	3.4k 1.0×	319	23.6k
Ansgar W. Lohse	10.8k 0.9×	12.4k 1.1×	4.3k 0.9×	3.0k 0.8×	1.9k 0.6×	485	19.5k
Claude Degott	8.3k 0.7×	8.3k 0.7×	3.3k 0.7×	2.1k 0.6×	2.7k 0.8×	318	18.1k
Geoffrey W. McCaughan	8.4k 0.7×	8.7k 0.8×	5.2k 1.1×	3.4k 0.9×	3.1k 0.9×	528	20.3k
Raymond T. Chung	12.9k 1.1×	13.5k 1.2×	1.9k 0.4×	3.1k 0.8×	3.7k 1.1×	431	23.1k
Tilman Sauerbruch	7.5k 0.6×	7.8k 0.7×	6.0k 1.2×	2.5k 0.7×	1.8k 0.6×	525	18.6k
Christian Trautwein	15.3k 1.3×	12.9k 1.1×	5.2k 1.1×	6.9k 1.8×	9.7k 3.0×	709	36.2k
Michael Fried	17.0k 1.5×	18.4k 1.6×	3.8k 0.8×	1.2k 0.3×	1.7k 0.5×	473	28.7k
Ralf Weiskirchen	7.0k 0.6×	6.5k 0.6×	2.5k 0.5×	2.6k 0.7×	6.0k 1.8×	489	19.0k
Michael Torbenson	12.7k 1.1×	9.2k 0.8×	4.0k 0.8×	802 0.2×	5.8k 1.8×	297	22.7k

Countries citing papers authored by Guido Gerken

Since Specialization

Citations

This map shows the geographic impact of Guido Gerken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Gerken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Gerken more than expected).

Fields of papers citing papers by Guido Gerken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Gerken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Gerken. The network helps show where Guido Gerken may publish in the future.

Co-authorship network of co-authors of Guido Gerken

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Gerken. A scholar is included among the top collaborators of Guido Gerken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Gerken. Guido Gerken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jacobson, Ira M., Stefan Bourgeois, Paul J. Thuluvath, et al.. (2023). The tolerability of sofosbuvir/velpatasvir for 12 weeks in patients treated in the ASTRAL 1, 2 and 3 studies: A pooled safety analysis. Journal of Viral Hepatitis. 30(5). 448–454. 1 indexed citations

Jahn, Michael, Jan Rekowski, Guido Gerken, et al.. (2019). The predictive performance of SAPS 2 and SAPS 3 in an intermediate care unit for internal medicine at a German university transplant center; A retrospective analysis. PLoS ONE. 14(9). e0222164–e0222164. 15 indexed citations

Walker, Andreas, et al.. (2017). The influence of immunosuppressants on direct‐acting antiviral therapy is dependent on the hepatitis C virus genotype. Transplant Infectious Disease. 20(1). 3 indexed citations

Theysohn, Jens, Marcus Ruhlmann, Stefan Müller, et al.. (2015). Radioembolization with Y-90 Glass Microspheres: Do We Really Need SPECT-CT to Identify Extrahepatic Shunts?. PLoS ONE. 10(9). e0137587–e0137587. 8 indexed citations

Beilfuss, A, Jan‐Peter Sowa, Svenja Sydor, et al.. (2014). Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently. Gut. 64(5). 791–799. 120 indexed citations

Canbay, Ali & Guido Gerken. (2014). Acute Liver Failure: A Dangerous and Challenging Syndrome. 91–98. 1 indexed citations

Schlaak, JF, Martin Trippler, Carolina Hoyo-Becerra, et al.. (2012). Selective Hyper-responsiveness of the Interferon System in Major Depressive Disorders and Depression Induced by Interferon Therapy. PLoS ONE. 7(6). e38668–e38668. 19 indexed citations

Beilfuss, A, et al.. (2011). Vitamin D ameliorates stress ligand expression elicited by free fatty acids in the hepatic stellate cell line LX-2. The Turkish Journal of Gastroenterology. 22(4). 400–407. 15 indexed citations

Cicinnati, Vito R., Jinyu Kang, Monika Lindemann, et al.. (2009). Interferon-α Differentially Affects Homeostasis of Human Plasmacytoid and Myeloid Dendritic Cells. Journal of Interferon & Cytokine Research. 29(3). 145–160. 6 indexed citations

10.

Kahraman, Alişan, et al.. (2009). Apoptosis in selected liver diseases. The Turkish Journal of Gastroenterology. 20(3). 171–179. 9 indexed citations

11.

Eggebrecht, Holger, Rajendra H. Mehta, Alexander Dechêne, et al.. (2009). Aortoesophageal Fistula After Thoracic Aortic Stent-Graft Placement. JACC: Cardiovascular Interventions. 2(6). 570–576. 101 indexed citations

12.

Wu, Jun, Zhongji Meng, Martin Trippler, et al.. (2008). 581 HBV SUPPRESSES TLR-MEDIATED INNATE IMMUNE RESPONSES IN MURINE PARENCHYMAL AND NON-PARENCHYMAL LIVER CELLS. Journal of Hepatology. 48. S217–S218. 2 indexed citations

13.

Beckebaum, Susanne, Vito R. Cicinnati, Christoph E. Broelsch, & Guido Gerken. (2006). Rezidiv der Grunderkrankung nach Lebertransplantation. Medizinische Klinik. 101(12). 939–950. 1 indexed citations

14.

Janssen, Harry L.A., Monika van Zonneveld, Hakan Şentürk, et al.. (2005). Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. The Lancet. 365(9454). 123–129. 866 indexed citations breakdown →

15.

Radecke, K, Nils R. Frühauf, Michael G. Miller, et al.. (2005). Outcome after orthotopic liver transplantation in five HIV‐infected patients with virus hepatitis‐induced cirrhosis. Liver International. 25(1). 101–108. 28 indexed citations

16.

Hilgard, Philip & Guido Gerken. (2004). Hepatische Enzephalopathie. Medizinische Klinik. 99(10). 591–602. 3 indexed citations

17.

Sturm, Andreas, et al.. (2002). Lisofylline and Lysophospholipids Ameliorate Experimental Colitis in Rats. Digestion. 66(1). 23–29. 32 indexed citations

18.

Loock, J., Guido Gerken, M. Malagò, et al.. (2001). Treatment of Split-Liver Recipients with Poor Graft Function by Albumin-Dialysis (Mars). Zeitschrift für Gastroenterologie. 39. 18–19. 6 indexed citations

19.

Krogsgaard, Kim, Niels Bindslev, Erik Christensen, et al.. (1994). The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. Journal of Hepatology. 21(4). 646–655. 70 indexed citations

20.

Gerken, Guido & K. H. Meyer zum Büschenfelde. (1991). Chronic hepatitis delta virus (HDV) infection.. PubMed. 38(1). 29–32. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact